Alimta

... Lilly profit boosted by newer products - Biotechnology - Health-Care - Medical Products - Company Announcements - Earnings E-mail: Password: Free membershipSpecial offersHelp Front PageMarketsGlobal MarketsEconomy & PoliticsMutual Funds/ETFsCommentaryIndustriesSpecial Reports ENTER SYMBOL(S) Quote/NewsChartsProfileAdvisersAnalystsInsidersOptionsFinancialsMessagesSEC FilingFind symbolKeyword search12 Free Trades, $100 Value -ShareBuilder BECOME A MEMBER

My Portfolios My Alerts e-Newsletters Discussions View all member benefits FREE!

SPONSORED LINKS Free Hot Stock Picks From The Stockster The Stockster issues free hot commonsense penny stock picks to turn your portfolio into a monster performer.

Bookmark our page for up to date movers and huge potential profits.

Free Report with 3 Energy Winners for 2 Winter’s energy panic!

Natural gas prices top $20 – that’s just the beginning.

Free energy report reveals truth about crisis and how you can profit.

WSJ.COM HIGHLIGHTSAvailable free to MarketWatch readers: Forget the car radio Internet browsers and word processors may be coming to your dashboard.

TOP SECTIONS In Katrina's Wake Corner Office Automobiles Banking Careers Retail & Consumer Health Care IPOs Small Business Technology Travel Upgrades/ Downgrades More features PREMIUM PRODUCTS Proactive Fund InvestorWith Bill Donoghue NEWMutual fund strategies...

... Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS of $1.81, or $2.87 Excluding Charges ...

DAX: 5516 (+1,63%) MDAX: 7900 (+1,21%) TecDAX: 668 (+1,51%) DOW J.: 10710 (-0,03%) NASDAQ Comp.: 2261 (-0,21%) Wertpapiersuche: Realtime-Kurse News Analysen Chart-Analyse IPO Termine Rohstoffe Insiderdaten Eurams-Premium Ticker Aktien Devisen Fonds Optionsscheine Knock-Outs Zertifikate Anleihen Aktienanleihen Forum Portfolio Lotto Stellenmarkt CFDs Suchmaschinen Immobilien Versicherung PDA Weitere News: Rubriken Ad hoc-Meldungen Neuemissionen Marktberichte Standardwerte Wachstumswerte Nebenwerte USA Asien International Biotech/Pharma Konjunktur/Wirtschaft Experten-Kolumnen Hugin/DGAP-News Pressemitteilungen PR Newswire deutsch PR Newswire englisch Businesswire englisch Euro am Sonntag Specials Börsenradio Technische Analysen Länder Australien Belgien Deutschland Europa Finnland Frankreich Griechenland Großbritannien Hong Kong Irland Italien Japan Kanada Mexiko Niederlande Norwegen Österreich Portugal Schweden Schweiz Singapur Spanien Tschechien USA Indizes DAX 30 TecDAX MDAX Nikkei 225 SMI Dow Jones 30 Industrial S&P 500 NASDAQ 100 Ad hoc News-Ticker Profisuche IR-Center Weitere Optionen zu Eli Lilly and Co.

[WKN: 858560] Kurse+Charts Realtime News+Analysen zugehörige Wertpapiere Einfügen in Fundamental Unternehmen Kurs + Chart Stuttgart News+Adhoc Zertifikate Depot Bilanz Termine Times + Sales Lang+Schwarz Analyse...

... Breaking News: Hana Biosciences Announces 2006 Corporate Goals; Key 2005 Achievements Reviewed and 2006 Objectives Announced; Annual Shareholder Meeting and a Pipeline Update Teleconference to Be Held on May 9, 2006 BODY { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: #ececec; PADDING-BOTTOM: 0px; MARGIN: 0px; FONT: 85% Arial, Helvetica, sans-serif; PADDING-TOP: 0px } Log in Register Now UPDATED 1/5/2006 6:58:00 AM EST Contact Us Mary Ann Liebert, Inc.

About GEN Home In The News Breaking News Sticky Ends Online Current Issue New Products On The Web Past Issues e-Newsletters Calendar of Events Classifieds View Listings Submit a Listing Web Resources Subscribe to GEN Reprints Advertise in GEN Media Kit Mailing List Rental Partnership Opportunities Editorial Editorial Calendar Meet the GEN Editors Editorial Guidelines Gen database of Biotech Firms Home » In The News » Breaking News Breaking News Email article to a colleague Printer friendly version Hana Biosciences Announces 2006 Corporate Goals; Key 2005 Achievements Reviewed and 2006 Objectives Announced; Annual Shareholder Meeting and a Pipeline Update Teleconference to Be Held on May 9, 2006 1/5/2006 6:00:00 AM EST Hana Biosciences (AMEX:HBX), a biopharmaceutical company focused on advancing cancer care, today reviewed 2005 progress and announced its corporate objectives for 2006.

Key 2005 achievements fo...